The Jurisdictional End-Around: Why the Eighth Circuit’s Roundup Dismissal Greenlights State-Court Settlement Strategy

In a decision that should send shivers down the spine of every federal MDL practitioner, the Eighth Circuit on August 27, 2026, dismissed an appeal by plaintiffs opposing Bayer’s $7.25 billion state-court class-action settlement of Roundup claims. The procedural effect is stark: the case remains in Missouri state court, blocking transfer to a federal judge who had criticized the proposal. This isn’t merely a jurisdictional skirmish—it’s a roadmap for defendants seeking to escape the perceived hostility of federal multidistrict litigation and the rigorous scrutiny of Rule 23.

The Eighth Circuit’s dismissal, while procedural in nature, carries substantive weight that extends far beyond the glyphosate litigation. By refusing to entertain the appeal, the court effectively validated a defense strategy that has been quietly gaining traction: when facing a skeptical federal judge in an MDL, pivot to a state-court class action where the rules of engagement differ dramatically. The implications for mass tort practice are profound and, frankly, troubling for those of us who believe federal courts provide the appropriate forum for nationwide product liability claims.

The CAFA Conundrum

The most perplexing aspect of this development is how it interacts with the Class Action Fairness Act of 2005, 28 U.S.C. § 1332(d). CAFA was specifically designed to funnel large, interstate class actions into federal court, precisely to avoid the kind of state-court favoritism that plagued the pre-2005 landscape. Yet here we have a $7.25 billion settlement—hardly a local dispute—remaining in Missouri state court while objectors are denied federal appellate review.

The Eighth Circuit’s dismissal suggests that the procedural posture matters more than the substantive stakes. If the settlement was structured as a state-court class action from the outset, rather than as a removal from federal court, CAFA’s jurisdictional hooks may not apply in the way objectors assumed. This creates a perverse incentive: defendants facing federal MDL pressure can simply file a parallel state-court class action, negotiate a global settlement, and dare objectors to challenge it in a forum where federal appellate courts may lack jurisdiction to intervene.

The Federal Judge Problem

The Reuters report notes that the Eighth Circuit’s ruling blocks transfer to a federal judge who had criticized the proposal. This detail is crucial. In the federal MDL system, judges like those presiding over the Roundup litigation have developed sophisticated frameworks for evaluating mass settlements, often appointing special masters, requiring detailed cy pres provisions, and scrutinizing attorney fee requests with a jaundiced eye. State courts, by contrast, vary widely in their approach to class settlement approval.

Missouri state courts, while certainly capable of rigorous review, operate under different procedural rules and cultural expectations than federal MDL transferee judges. The Eighth Circuit’s dismissal effectively allows Bayer to forum-shop for a more receptive audience, undermining the uniformity that CAFA was designed to promote. For plaintiffs’ lawyers who have spent years building expertise in federal MDL practice, this represents a significant strategic setback.

The Objector’s Dilemma

The plight of the objecting plaintiffs in this case illustrates a broader problem in modern class-action practice. Under Rule 23(e), objectors have limited rights to challenge settlements, and their ability to appeal is often contingent on meeting stringent requirements. When the settlement is structured to avoid federal jurisdiction entirely, objectors may find themselves with no meaningful avenue for appellate review, as the Eighth Circuit’s dismissal demonstrates.

This creates a dangerous precedent. If defendants can immunize settlements from federal appellate scrutiny by keeping them in state court, the careful balance struck by Rule 23—between finality and fairness, between efficiency and due process—tilts decisively toward finality at the expense of fairness. The Eighth Circuit’s decision, while perhaps technically correct on jurisdictional grounds, undermines the substantive protections that federal courts have developed for absent class members.

What This Means for Practice

For defense counsel, the message is clear: consider state-court class actions as a viable alternative to federal MDL settlement, particularly when facing a skeptical federal judge. The Eighth Circuit’s dismissal suggests that objectors may have limited recourse once the settlement is lodged in state court, especially if the case was never properly removed to federal court in the first place.

For plaintiffs’ counsel, the lesson is equally stark: be vigilant about removal strategy and CAFA jurisdiction from the outset. If a defendant files a parallel state-court class action, immediate removal under CAFA may be essential to preserve federal oversight. Once the settlement is approved in state court and federal appellate review is foreclosed, the battle may be lost.

For class-action objectors and public-interest lawyers, this development is a call to action. The Eighth Circuit’s dismissal highlights the need for legislative or rule-based reforms to ensure that large, interstate settlements cannot evade federal scrutiny through procedural maneuvering. CAFA’s jurisdictional provisions may need to be revisited to close this emerging loophole.

The Bigger Picture

This development fits into a broader pattern of federal appellate courts policing the boundaries of class-action procedure, as evidenced by the other 2026 decisions in the search results: the Third Circuit’s revival of the casino AI antitrust class action, the Seventh Circuit’s vacatur of the Clearview AI settlement, and the Seventh Circuit’s limited grant of Rule 23(f) review in the elite-university financial-aid case. Federal courts are actively shaping the contours of class-action practice, but the Eighth Circuit’s Roundup dismissal suggests that state courts may become the new battleground for settlement approval.

The tension between federal MDL efficiency and state-court autonomy is not new, but the Eighth Circuit’s decision tilts the balance in a way that should concern anyone who values consistent, rigorous review of mass settlements. As AI-driven pricing cases, privacy class actions, and antitrust MDLs continue to proliferate, the forum in which these cases are resolved may prove as important as the substantive law that governs them.

The Eighth Circuit’s dismissal may be remembered as the moment when the federal MDL monopoly on mass tort settlements began to crack. Whether that’s a feature or a bug depends on your perspective—but there’s no denying that the landscape has shifted.